TARDBP and neurodegenerative disease: Amongst all non-neurodegenerative disease brains (i.e. brain bank controls) constituting the ageing cohorts, TDP-43 pathology was detected in 54.5% (18/33; CI 38.0–70.2%) of individuals (Figure 3A, Table 3).